Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Patent opposition analysis in Large Peptides industry

In the competitive field of Large Peptides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Large Peptides technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Large Peptides Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
STRAWMAN30
JAMES POOLE21
MAIWALD11
HOFFMANN EITLE11
MARGARET DIXON10
PFIZER8
BOULT WADE TENNANT8
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB8
MERCK SHARP & DOHME7
DR H ULRICH DORRIES7

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
GENENTECH35
AMGEN15
NOVARTIS14
MODERNATX12
MODERNA THERAPEUTICS10
BAXALTA INCORPORATED10
GLAXOSMITHKLINE BIOLOGICALS10
BAXALTA10
CHUGAI SEIYAKU KABUSHIKI KAISHA10
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA10

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
CARPMAELS & RANSFORD34
MEWBURN ELLIS20
HOFFMANN EITLE19
MAIWALD18
D YOUNG14
ZWICKER10
BOULT WADE TENNANT10
DORRIES8
J A KEMP7
KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF7

Latest patents opposed in the Large Peptides industry

Patent challenges are becoming increasingly common in the Large Peptides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Large Peptides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Large Peptides industry

EP3515475Chimeric Antigen Receptor (Car) That Targets Chemokine Receptor Ccr4 And Its UseTHE USA REPRESENTED BY THE SECRETARYJan 30, 2025WEICKMANN & WEICKMANN PARTMBB
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS
EP4069368Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
EP3307765Recombinant Protein Fiber Yarns With Improved PropertiesBOLT THREADSJan 9, 2025ZWICKER SCHNAPPAUF & PARTNER PATENTANWALTE PARTG MBB
EP4368705Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTISJan 2, 2025CENTURY THERAPEUTICS
EP3226887Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3402812Modulators Of Zinc Activated Cation ChannelDIGNITY HEALTHDec 13, 2024BLUM
EP4069368Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSDec 9, 2024CARPMAELS & RANSFORD SPECIALITIES
EP3530670Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKUNov 22, 2024POHLMAN
EP3585402Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell TherapyJUNO THERAPEUTICSNov 12, 2024BOULT WADE TENNANT

Top patents facing oppositions in Large Peptides industry

To stay ahead in the competitive Large Peptides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Large Peptides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2188302Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10
EP3597659Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
EP2586788Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
EP2261230May 10, 2017Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHA7
EP1974014Apr 19, 2017Oligopeptide-Free Cell Culture MediaBAXTER6
EP3227454Jan 29, 2020Process For Manipulating The Level Of Glycan Content Of A GlycoproteinAMGEN5
EP2784084Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofNOVARTIS5
EP3173092Jun 26, 2019Rna Containing Composition For Treatment Of Tumor DiseasesCUREVAC5
EP3883606Nov 20, 2024Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECH5